Regencell BioscienceRGC
RGC
About: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Employees: 12
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
5,209% more capital invested
Capital invested by funds: $1.89K [Q2] → $100K (+$98.6K) [Q3]
0.13% more ownership
Funds ownership: 0% [Q2] → 0.14% (+0.13%) [Q3]
33% less funds holding
Funds holding: 3 [Q2] → 2 (-1) [Q3]
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Research analyst outlook
We haven’t received any recent analyst ratings for RGC.
Financial journalist opinion
Charts implemented using Lightweight Charts™